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Abstract
Background: The aim of this study was to investigate the in vitro effects of the Fusarium fungus-derived
mycotoxin, zearalenone and its derivatives alpha-zearalenol and beta-zearalenol on motility parameters and the
acrosome reaction of stallion sperm. Since the toxic effects of zearalenone and its derivatives are thought to result
from their structural similarity to 17beta-estradiol, 17beta-estradiol was used as a positive control for ‘estrogen-like’
effects.
Methods: Stallion spermatozoa were exposed in vitro to zearalenone, alpha-zearalenol, beta-zearalenol or 17beta-
estradiol at concentrations ranging from 1 pM - 0.1 mM. After 2 hours exposure, motility parameters were
evaluated by computer-assisted analysis, and acrosome integrity was examined by flow cytometry after staining
with fluoroscein-conjugated peanut agglutinin.
Results: Mycotoxins affected sperm parameters only at the highest concentration tested (0.1 mM) after 2 hours
exposure. In this respect, all of the compounds reduced the average path velocity, but only alpha-zearalenol
reduced percentages of motile and progressively motile sperm. Induction of motility patterns consistent with
hyperactivation was stimulated according to the following rank of potency: alpha-zearalenol >17beta-estradiol >
zearalenone = beta-zearalenol. The hyperactivity-associated changes observed included reductions in straight-line
velocity and linearity of movement, and an increase in the amplitude of lateral head displacement, while curvilinear
velocity was unchanged. In addition, whereas alpha- and beta- zearalenol increased the percentages of live
acrosome-reacted sperm, zearalenone and 17beta-estradiol had no apparent effect on acrosome status. In short,
alpha-zearalenol inhibited normal sperm motility, but stimulated hyperactive motility in the remaining motile cells
and simultaneously induced the acrosome reaction. Beta-zearalenol induced the acrosome reaction without
altering motility. Conversely, zearalenone and 17beta-estradiol did not induce the acrosome reaction but induced
hyperactive motility albeit to a different extent.
Conclusions: Apparently, the mycotoxin zearalenone has 17beta-estradiol-like estrogenic activity that enables it to
induce hyperactivated motility of equine sperm cells, whereas the zearalenol derivatives induce premature
completion of the acrosome reaction and thereby adversely affect stallion sperm physiology. The alpha form of
zearalenol still possessed the estrogenic ability to induce hyperactivated motility, whereas its beta stereo-isomere
had lost this property.
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Zearalenone (ZEA) is an estrogenic mycotoxin bio-
synthesized by a variety of fungal species of the genus
Fusarium, which are commonly found in the soil in
temperate and warm countries and are frequent con-
taminants of cereal crops worldwide [1]. The toxic
effects of Zearalenone and its metabolites have been
ascribed primarily to its chemical structure that resem-
bles that of naturally occurring estrogens [2]. Zearale-
none is rapidly absorbed following oral intake and,
during subsequent metabolism mainly in the liver and
intestine, it is transformed into a-a n db-zearalenol (a-
and b-ZOL), a-a n db-zearalanol (a-a n db-ZAL) and
zearalanone (ZAN), all of which are subsequently conju-
gated to glucuronic acid [2]. A variety of other tissues,
including the kidney, testis, prostate, hypothalamus and
ovary, also contain the major enzymes (3a-a n d3 b-
hydroxysteroid dehydrogenase) able to metabolize myco-
toxins [3]. Elimination of ZEA and its derivatives occurs
mainly via the urine [4]. Zearalenone and its derivatives
are thought to exert toxicity both by competitive bind-
ing to specific estrogen receptors and by modification of
steroid metabolism [5].
In the horse, urinary concentrations of ZEA and its
derivatives after natural exposure have been reported to
range from 0.5 nM to 6.8 μM [6,7]. In pigs, levels of
ZEA and a-ZOL ranging from 8.2 nM to 1 μMa n d
from 0.13 μMt o0 . 8 7μM have been detected in blood
plasma and urine, respectively, during experimental
intoxication [8-12]; i.e., the concentrations were found
to be higher in urine than blood. In follicular fluid from
naturally exposed pigs and cattle, ZEA and its deriva-
tives have been detected at levels ranging from 30 pM
to 0.2 nM and from 10 to 60 pM, respectively [13,14].
However, there are no reports of the concentrations of
ZEA and its derivatives in body fluids of horses during
experimental intoxication, and no data is available for
the concentrations of mycotoxins in seminal plasma.
In domestic animal species, putative toxic effects of
ZEA on reproductive performance have been investi-
gated primarily in female animals, particularly cattle and
pigs, whereas relatively few studies have examined the
influence of ZEA on male reproductive function [15]. In
adult rams, however, daily intake of 12 mg ZEA for 8
weeks during the breeding season affected sperm pro-
duction and the percentages of motile and morphologi-
cally normal sperm [16]. To our knowledge, there are
n or e p o r t so ft h ee f f e c t so fZ EA and its derivatives on
semen quality or fertility in bulls. In pigs, in vitro studies
have reported toxic effects of ZEA and its derivatives on
sperm parameters thought to be important for fertility
[17-19]; in particular, ZEA and its derivatives reduced
the percentages of viable and progressively motile sperm
[17,19] and the percentages of sperm able to undergo
the acrosome reaction (AR) [17] or which contained
stable chromatin [18,19]. All of these changes would be
expected to reduce fertilizing capacity, and may in part
explain the observed reductions in farrowing rate and
total number of piglets born in ZEA affected pig herds
[17].
In contrast to pigs and ruminants, horses are thought
to be relatively insensitive to the effects of ZEA on
reproductive function. Aurich et al. [20] reported that
the concentrations of the toxin found in naturally con-
taminated oats had no significant effect on the release
of reproductive hormones, cycle length, or uterine his-
tology in mares. On the other hand, we previously
reported toxic effects at the level of sperm chromatin
stability in equine sperm exposed to low concentrations
(up to 0.025 pM) of ZEA and its derivatives (a-ZOL, b-
ZOL, a-ZAL, b -ZAL and ZAN) in vitro, suggesting that
a genotoxic effect was being stimulated by a non-geno-
mic mechanism [6].
A significant body of experimental evidence has also
been accumulated to suggest that steroid hormones
can influence reproductive function via plasma mem-
brane receptors and, thereby, exert their effects via
non-genomic pathways. For example, Giammarino et
al. [21] reported that ZEA, a-ZOL and b-ZOL rapidly
enhanced spontaneous contraction of isolated lamb
uterine smooth muscle in a fashion similar to 17b-
estradiol (E2); this supported the existence of non-
genomic pathways for the actions of sex steroids
because the effect was too rapid to be explained by
transcription of RNA and subsequent protein synthesis.
The concept that steroid hormones may act via path-
ways other than the classical genomic route has
attracted particular attention for sperm since the latter
are transcriptionally inactive. Indeed, the demonstra-
tion that sex steroids can affect sperm function has
helped to strengthen the idea that steroids can act via
non-genomic pathways [22]. To date, however, studies
on the effects of estrogens on sperm function are lim-
ited in number, and both species-specific differences
and apparently contradictory results have been
reported. Baldi et al. [22] performed an exhaustive
review of recent investigations into non-genomic acti-
vation of spermatozoa by steroid hormones; they con-
cluded that in vitro treatment of human sperm with E2
induces a small rise in intracellular calcium concentra-
tions that, ultimately, inhibits the progesterone-
induced AR. However, E2 did not appear to directly
affect the AR. These effects of E2 on human sperm
were recently confirmed by Vigil et al. [23]. By con-
trast, Francavilla et al. [24] reported that pre-incuba-
tion with E2 did not alter the ability of human sperm
to fuse with an oocyte, nor did it interfere with the
ability of progesterone to enhance this process.
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blood plasma [25,26] and from 10 pM to 2 nM in semi-
nal plasma [25-27] have been reported. In the follicular
fluid of mares, E2 concentrations are generally higher
and more variable, at between 20 nM and 11 μM
[28-32].
To our knowledge, there are no reports of the effects
of ZEA or its derivatives on sperm motility and the AR
in the horse. The aim of the present study was to deter-
mine whether ZEA and its derivatives, a-ZOL and b-
ZOL, exert dose-dependent effects on equine sperm
motility, including hyperactive motility, as assessed by
computer assisted sperm analysis (CASA), and/or on the
AR, as assessed by fluoroscein isothiocyanate conjugated
peanut agglutinin (FITC-PNA) staining and flow cyto-
metry. To further clarify whether the effects of mycotox-
ins on stallion sperm could be considered to be
estrogen-like, the effects of in vitro exposure of sperm
to E2 were also investigated.
Methods
Materials
The following key reagents were used in these studies;
propidium iodide (PI, Molecular Probes, Eugene, OR),
fluorescein isothiocyanate conjugated peanut (Arachis
hypogea) agglutinin (FITC-PNA, EY laboratories inc.,
San Mateo, CA), E2,Z E A ,a-ZOL and b-ZOL (all
Sigma, St Louis, MO).
Semen collection and preparation
During the breeding season (March to June 2009),
semen was collected repeatedly from five adult stallions.
During the experimental period, stallions were housed
in straw-bedded boxes and were managed and used in
accordance with local health and welfare regulations
under strict uniform conditions to ensure that variability
in repeated experiments (replicates = 3) were minimally
affected by external factors. The use of in-field collected
equine semen would not have allowed the present stu-
dies because of the potentially large differences in man-
agement, feeding and housing. Semen was collected
using a Hannover model artificial vagina and immedi-
ately filtered though sterile gauze to remove the gel frac-
tion and any debris. The gel-free semen volume was
measured using a graduated cylinder, and the initial per-
centage of motile sperm was estimated by microscopic
evaluation; a total motility of ≥ 60% was considered
acceptable for subsequent use. Semen samples were
washed in HEPES-buffered Tyrode’s solution (HBT; 120
mM NaCl, 21.7 mM lactate, 20 mM Hepes, 5 mM glu-
cose, 3.1 mM KCl, 2.0 mM CaCl2, 1.0 mM pyruvate, 0.4
mM MgSO4, 0.3 mM NaH2PO4 and 100 μg/ml kanamy-
cin; 300 mOsm/kg, pH 7.4) by centrifugation three
times for 5 minutes at 600 × g to remove seminal
plasma. After each washing step, the sperm pellet was
re-suspended in HBT at a concentration of approxi-
mately 100 × 10
6 spermatozoa/ml.
Prior to incubation, HBT medium was supplemented
with 5 mg/ml of BSA and 15 mM bicarbonate (HBT
+BIC) and brought into equilibrium with 5% CO2 in
humidified air (i.e. capacitating conditions).
Incubation of spermatozoa with 17b-estradiol and
mycotoxins
Stock solutions were prepared for E2,Z E A ,a-ZOL and
b-ZOL by dissolving them in dimethyl sulphoxide
(DMSO) at a concentration of 100 mM. Subsequently,
nine concentrations of E2 and each mycotoxin, ranging
from 20 × 10
-5 μMt o2 0×1 0
3 μM, were prepared by
serial 1:10 dilution of stock solution with DMSO.
The maximum amount of DMSO that did not nega-
tively affect viability, motility or acrosome integrity of
stallion sperm was achieved at a 1:200 dilution (reagent
in incubation medium). Subsequently, in all experiments,
at o t a lo f5μl of the various concentrations of E2 or ZEA
derivatives was added to 995 μlo fs p e r ms u s p e n d e di n
HBT+BIC at a final concentration of 20 × 10
6 spermato-
zoa/ml such that the final concentration of tested com-
pounds ranged from 1 pM to 0.1 mM. This wide range of
concentrations tested encompassed those reported for
ZEA, its derivatives and E2 in biological fluids, but also
included concentrations approximately 10 times higher
and 10 times lower than those expected in vivo. Control
observations were performed in the absence of the test
compounds and analyzed at time 0 and after 2 hours of
incubation at 38.5°C in an atmosphere of 5% CO2-in-air.
Further controls were performed by adding 5 μlD M S O
to the sperm suspension and tested after 2 hour incuba-
tion. Experimental measurements were performed at the
end of the 2 hour incubation.
Sperm motility analysis
Computer-assisted sperm motility analysis (CASA) was
performed using a Sperm Vision
® (Minitüb GmbH, Tie-
fenbach, Germany) system equipped with a heated stage.
Seven motility parameters were recorded for subsequent
analysis; percentages of motile sperm (total and progres-
sively motile), the average path velocity (VAP; expressed
in μm/sec), the straight-line velocity (VSL; μm/sec), the
curvilinear velocity (VCL; μm/sec), the amplitude of lat-
eral head displacement (ALH; μm) and the linearity
(LIN;%). Each evaluation was performed at the same
sperm concentration (20 × 10
6 spermatozoa/ml) and
included analysis of 12 microscope fields (as suggested
by the manufacturer) in three ejaculates recovered from
each of the five stallions included in the study. For each
motility parameter, data were recorded as mean (± stan-
dard deviation).
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Acrosome status and sperm viability were examined
simultaneously by staining samples with 1 μg/ml FITC-
PNA and 1 μM PI, respectively. Sperm samples were incu-
bated in the dark for 10 minutes at 37°C in an atmosphere
of 5% CO2-in-air. Sperm suspensions were then further
diluted with HBT+BIC to a concentration of 2 × 10
6 sper-
matozoa/ml before flow cytometric analysis (FACScan,
Becton Dickinson, San Jose, CA), which involved the
acquisition of 10,000 events at a flow rate of approximately
200 cells per second, as described by Flesch et al. [33]. The
resulting data was analyzed using Cell-Quest software
(Becton Dickinson). Samples incubated in the presence of
1 μM calcium ionophore A23187 were used as positive
controls for the induction of the AR. The percentages of
live, acrosome-reacted and of dead cells were recorded.
For each of the five stallions, each compound was tested
on one ejaculate over the full range of concentrations.
Statistical analysis
Data for motility parameters and acrosome status were
analyzed using mixed model analyses of variance from
the SAS™ package v. 9.1, (SAS Institute, Cary, NC). In
the models, the dose-response effects of E2, ZEA and its
derivatives (a-ZOL and b- Z O L )w e r ec o n s i d e r e da s
fixed effects, whereas the stallion was treated as a ran-
dom effect. Repeatability of motility parameters was
computed from the components of variance obtained by
a mixed model procedure on several individuals from
which two or more measurements were performed.
Results
In this study, most of the motility parameters and the
percentages of sperm undergoing the AR were signifi-
cantly and dose-dependently influenced by addition of E2
or the mycotoxin ZEA and its derivatives, as shown in
Table 1. A significant influence of stallion was also evi-
dent for all parameters measured (Table 1). By using a
mixed model procedure, the dose-response effects of E2,
ZEA and its derivatives (a-ZOL and b-ZOL) were tested
after correction for the stallion effect. Moreover, accepta-
ble (>0.5) repeatability (on the basis of homogeneity of
measurements within individual stallions) was found for
all parameters, as shown in Table 1. The adverse and
positive effects of the four estrogenic substances on
sperm motility are detailed i nF i g u r e s1 ,2 ,3a n d4 ,a n d
those for the induction of the AR in Figure 5; all effects
are also described below in the specific results sections.
Dose-dependent effect of in vitro exposure to 17b-
estradiol, zearalenone and its derivatives on sperm
motility
Motility parameters observed in sperm samples exposed
in vitro to E2,Z E A ,a-ZOL and b-ZOL are depicted in
Table 1 The effect of concentration, substance and stallion on sperm parameters (P values) and repeatability values
Effect Total motility Progressive motility VAP VCL VSL ALH LIN Acrosome reaction
concentration 0.053 0.004 <0.0001 0.007 <0.0001 <0.0001 <0.0001 0.006
substance 0.32 0.08 0.27 0.0004 0.051 <0.0001 0.0007 <0.0001
stallion <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
repeatability 0.54 0.61 0.63 0.81 0.59 0.7 0.63 n.e.
n.e. = not evaluated due to the absence of replicates
n = 5, replicates = 3 for motility parameters; n = 5, no replicates for acrosome reaction
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Figure 1 Dose-response effect of estrogenic mycotoxins and
17b-estradiol on total and progressive motility of stallion sperm.
As shown in panels a and b, in vitro exposure to 0.1 mM a-ZOL
significantly depressed total (p < 0.05) and progressive (p = 0.0001)
motility, compared to controls ("0 μM”). Zearalenone, b-ZOL and E2 did
not affect these two motility parameters at any concentration
examined. Least Square Means obtained by the mixed model
procedure. Different letters indicate values that differ significantly. a vs
b=p<0 . 0 5 ;avs c = p = 0.0001; n = 5, replicates = 3.
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Figure 2 Dose-response effect of estrogenic mycotoxins and 17b-estradiol on VAP, VSL and VCL of stallion sperm. As shown in panel a,
VAP was significantly reduced after in vitro exposure to 0.1 mM ZEA (p < 0.0001), a-ZOL ( p < 0.0001), b-ZOL (p < 0.05) and E2 (p < 0.05)¸
compared to controls ("0 μM”). Panel b: VSL was significantly reduced after in vitro exposure to 0.1 mM ZEA (p < 0.05), a-ZOL (p < 0.0001) and
E2 (p < 0.05), compared to controls ("0 μM”). Panel c: Estrogenic mycotoxins and E2 did not modify VCL at any concentration examined. Different
letters indicate values that differ significantly a vs b = p < 0.05; a vs c = p < 0.0001; n = 5, replicates = 3.
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derivatives induced hyperactivation of the motile sperm
(an index of capacitation), four motility parameters,
namely VSL, VCL, ALH and LIN were examined as sti-
pulated below. These motility parameters were chosen
as they have been shown to change during equine
sperm hyperactivation; in this respect, VCL and ALH
have been reported to increase, and VSL and LIN to
decline [34,35].
17b-Estradiol
In vitro exposure to E2 did not modify total or progres-
sive motility at any concentration examined (Figures 1a
and 1b) when compared to controls (2 hour exposure to
DMSO without E2). On the other hand, at a concentra-
tion of 0.1 mM, E2 significantly reduced VAP and VSL
(p < 0.05; Figures 2a and 2b), whereas it had no effect
on VCL (Figure 2c) or ALH (Figure 3), and caused a
reduction in LIN (p < 0.05; Figure 4),
Zearalenone
In vitro exposure to ZEA did not alter total or progres-
sive motility at any concentration examined (Figures 1a
and b). At a concentration of 0.1 mM, ZEA significantly
reduced VAP (p < 0.0001; Figure 2a) and VSL (p < 0.05;
Figure 2b), whereas it had no effect on VCL (Figure 2c),
ALH or LIN at any of the examined concentrations
(Figures 3 and 4).
a-Zearalenol
In vitro exposure to 0.1 mM a-ZOL significantly
depressed total (p < 0.05) and progressive (p 7 = 0.0001)
motility (Figures 1a and 1b). In addition, exposure to 0.1
mM a-ZOL reduced VAP (p < 0.0001; Figure 2a), VSL
(p < 0.0001; Figure 2b) and LIN (p < 0.0001; Figure 4),
b u td i dn o ta f f e c tV C L( F i g u r e2 c )a n dc a u s e da n
increase in ALH (p < 0.05; Figure 3).
b-Zearalenol
In vitro exposure to b-ZOL did not affect total or pro-
gressive motility at any concentration examined (Figures
1a and b). At 0.1 mM, b-ZOL significantly reduced VAP
(p < 0.05; Figure 2a) and LIN (p < 0.05; Figure 4),
Figure 3 Dose-response effect of estrogenic mycotoxins and
17b-estradiol on lateral head displacement (ALH) of stallion
sperm. In vitro exposure to 0.1 mM a -ZOL significantly increased (p
< 0.05) ALH, compared to control ("0 mM”), whereas ZEA, b-ZOL
and E2 did not modify this parameter at any concentration
examined. Different letters indicate values that differ significantly a
vs b = p < 0.05; n = 5, replicates = 3.
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Figure 4 Dose-response effect of estrogenic mycotoxins and
17b-estradiol on linearity (LIN) of stallion sperm. In vitro
exposure to 0.1 mM a-ZOL, b-ZOL and E2 significantly reduced LIN
(p < 0.0001; p < 0.05 and p < 0.05, respectively), compared to control
("0 μM”), whereas ZEA did not modify this parameter at any
examined concentration. Least Square Means obtained by the mixed
model procedure. Different letters indicate values that differ
significantly a vs b = p < 0.05; a vs c = p < 0.001; n = 5, replicates = 3.
Figure 5 Dose-response effect of estrogenic mycotoxins and
17b-estradiol on proportion of live acrosome-reacted stallion
sperm. Exposure to a- and b-ZOL at a concentration of 0.1 mM
significantly increased the percentage of (live) acrosome reacted
sperm (p < 0.0001 and p < 0.05, respectively), when compared to
controls ("0 μM”). No effects of ZEA or E2 on the percentage of live
acrosome reacted cells were observed. Different letters indicate
values that differ significantly a vs b = p < 0.05; a vs c = p < 0.001;
n=5 .
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c) or ALH at any examined concentration.
Acrosome integrity and sperm viability after in vitro
exposure to 17b-estradiol and mycotoxins
No effects of E2 or ZEA on the percentage of live acro-
some reacted sperm (Figure 5) were observed, when
compared to controls. However, exposure to a-ZOL or
b-ZOL, at a concentration of 0.1 mM, significantly
increased the percentage of live acrosome-reacted sperm
(p < 0.0001 and p < 0.05, respectively). When cells were
exposed to calcium ionophore, as a positive control for
the induction of the AR, the percentage of live acro-
some-reacted sperm also (p < 0.0001) increased signifi-
cantly (10.6%), when compared to controls (7.6%). The
percentage of dead cells was not affected by exposure to
either E2, ZEA or its derivatives at any of the examined
concentrations (data not shown).
Discussion
In the present study, we analyzed the effects of myco-
toxins and E2 on motility (including characteristics of
hyperactivated motility) and acrosome integrity in stal-
lion sperm exposed to E2 or estrogenic mycotoxins for 2
hours. In general, it is accepted that capacitation and
hyperactivation are linked events in the continuum of
changes that a sperm must undergo in preparation for
fertilization of an oocyte, and previous reports have sug-
gested that stallion sperm require relatively long incuba-
tions to induce signs of capacitation [34-38]. For
example, McPartlin et al. [35] reported that a 6 hour
incubation was needed to observe procaine-induced
hyperactivation in stallion sperm. In the present study, a
2 hour incubation was chosen for both motility (CASA)
and flow cytometric analysis because, in our experimen-
tal conditions, longer incubation times (e.g. 4 hours) sig-
nificantly reduced sperm viability. Moreover in a
previous study [6], we reported deleterious effects of
mycotoxins on the chromatin structure stability of stal-
lion sperm after 2 hours of incubation.
The results of the present study indicate that a 2 hour
in vitro exposure to a-ZOL affected proportions of
motile sperm (total and progressive motility) only when
the toxin was present at a high concentration (0.1 mM).
The effects of a-ZOL on the proportion of motile
equine sperm resembled those previously reported for
ZEA and a-ZOL on boar sperm [17,18], even though
different experimental conditions were used in the ear-
lier studies. In the current study, exposure to E2 did not
affect the percentages of motile sperm (total or progres-
sive); this corresponds with the findings of Luconi et al.
[39] for human sperm. On the other hand, at high con-
centrations (0.1 mM) both E2 a n dZ E Aa n di t sd e r i v a -
tives affected VAP; this suggests that, while the
percentages of motile sperm are not affected by estro-
genic mycotoxins, the speed at which the sperm move is
consistently reduced by exposure to this family of myco-
toxins. In particular, a pronounced reduction in VAP
was observed after exposure to a-ZOL or ZEA. Again,
the findings for the effect of E2 are in agreement with
those reported by Luconi et al. [40] for human sperm.
With respect to the effects on motility parameters, the
following rank of activity was apparent: a-ZOL > ZEA >
b-ZOL = E2. Moreover, at the concentrations examined,
a-ZOL was the only ZEA derivative able to reduce the
proportion of motile sperm in stallion semen, whereas
all the tested mycotoxins influenced the velocity of
sperm movement of the remaining motile cells and, in
addition, there was a trend for the sperm motility para-
meters to change in a way suggesting hyperactivation of
motility; i.e., reductions in VSL and LIN and a concomi-
tant increase in ALH. More specifically, at the highest
tested concentration (0.1 mM), ZEA inhibited VSL, a-
ZOL reduced VSL and LIN and increased ALH, and b-
ZOL reduced LIN. At the same concentration, E2
reduced VSL and LIN. In the only previous report [19]
of the effect of ZEA derivatives on sperm motility para-
meters, b-ZOL and a-ZOL were found to stimulate
VCL in boar sperm when introduced at concentrations
ranging from 0.2 to 20 μM, after 5 hours of incubation.
T h ec u r r e n ts t u d yi st h ef i r s tt oe x a m i n et h ee f f e c t so f
E2 on sperm motility parameters associated with hyper-
activation. The ranking of the effects on hyperactiva-
tion-related motility parameters in stallion sperm was a-
ZOL > E2 > ZEA = b-ZOL.
Neither ZEA nor E2 influenced the proportion of live
acrosome-reacted sperm during a 2 hour incubation. By
contrast, 0.1 mM a-ZOL or b-ZOL stimulated an
increase in the percentage of live acrosome-reacted
sperm. In a previous study on pig sperm [17], ZEA and
a-ZOL at higher concentrations (125 to 250 μM)
reduced the proportion of live acrosome-reacted cells
and concomitantly increased the proportion of deterio-
rated (dead) sperm. These conflicting results could
relate to differences in the experimental conditions
used, such as incubation time and methods of determi-
nation. We did not observe the deterioration effect and,
besides the likely contribution of the relatively short
incubation employed in the current study, we note the
advice that detection of the acrosome status of incu-
bated sperm should preferably be performed at the incu-
bation temperature because temperature shock can
easily induce membrane damage [41]. In the present
study, E2 did not influence the percentage of live acro-
some-reacted sperm.
Conflicting data on whether, and at what molecular
level, estrogens may affect the AR are still not comple-
tely resolved. The currently favored theory is that E2
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Page 7 of 10inhibits the progesterone- or ATP-induced AR in both
human [23,42,43] and bovine [44] sperm. However, stu-
dies in the mouse have documented a stimulatory effect
of E2 on the AR [45,46]. On the other hand, it may be
significant that different incubation conditions (medium,
time), staining (FITC-PNAo rF I T C - P i s u ms a t i v u m
agglutinin – PSA) and evaluation techniques (fluores-
c e n c em i c r o s c o p eo rf l o wc y t o m e t r y )w e r eu s e di nt h e
various studies. In the current study, a ranking of the
magnitude of the effect on the AR of stallion sperm was
Beta-zearalenol > b-ZOL > E2 = ZEA.
In the present study, a 2 hour incubations in the pre-
sence of ZEA, its derivatives or E2 were sufficient to
induce changes in equine sperm motility, hyperactivated
motility, and in the percentage of sperm that had acro-
some-reacted. The most potent compound was a-ZOL,
which modified sperm motility (total and progressive
motility), sperm velocity (VAP), most of parameters
related to hyperactive motility (VSL, LIN and ALH) and
induced the AR to a larger extent than any of the other
estrogenic compounds studied. Beta-zearalenol affected
only the percentage of acrosome-reacted sperm. As a
result of the contrasting effects of related chemicals,
there must be suspicions that, in the stallion, the path-
ways that regulate capacitation and hyperactivation are
separate and independent, as previously reported in
other species [47-49].
Apparently, the mycotoxin ZEA influenced hyperacti-
vation-associated parameters to a lesser extent than E2,
whereas both ZOL derivatives induced premature acro-
some reactions and thereby adversely affected the ferti-
lizing capacity of stallion sperm. The a isomer of ZOL
still possessed the apparently estrogenic capacity to
induce hyperactivated motility, whereas the b stereo-iso-
mer had lost this property.
Importantly, the current study showed that neither
ZEA, its derivatives nor E2 affected sperm cell deteriora-
tion during the 2 hour incubation. Previous studies
reported a significant decrease in the percentage of
viable boar sperm after in vitro exposure to ZEA, a-
ZOL and b-ZOL [17,19]; however, this occured at
higher concentrations of mycotoxin [17] and at longer
incubation times than in the present study [19].
Conclusions
In the experimental conditions used, a-ZOL was the
only ZEA derivative able to decrease the percentage of
motile sperm cells, induce changes in motility character-
istics of the remaining motile sperm consistent with
hyperactivation, and induce the AR in stallion sperm.
Zearalenone and b-ZOL induced only some of the moti-
lity parameters characteristic of hyperactivation and, of
the two, only b-ZOL induced the AR. None of the
mycotoxins behaved identically to E2, which induced
hyperactivation-like changes in sperm motility without
inducing the AR. These results differ to those reported
in other species, probably in large part because of the
different experimental conditions employed. It is, how-
ever, of interest that ZEA and E2 had similar effects
restricted to stimulating hyperactivation of stallion
sperm, while both ZOL stereo-isomers had additional
effects at the level of AR induction. The effect on hyper-
activation of sperm was also present for a-ZOL (and
even more potent) but was lost for the stereo-isomer b-
ZOL. This suggests that metabolism of ZEA converts an
i n i t i a l l ye s t r o g e n i cc o m p o u n di n t o( a )am o r ea c t i v e
component with respect to its capacity to induce hyper-
activation of equine sperm and (b) a compound capable
of additional activation of the AR. Both effects are pre-
sumably elicited at a premature (i.e. before sperm-oocyte
interaction in the oviduct) stage of reproductive physiol-
o g ya n da r et h e r e f o r el i k e l yt oinhibit fertilizing poten-
tial of affected sperm.
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